Jason Tardio
Fortune : 18 715 $ au 31/05/2026
Fortune : 18 715 $ au 31/05/2026
Mr. Jason Tardio is a President & Chief Operating Officer at Immunic, Inc. Mr. Tardio was previously employed as a Chief Operating Officer by Ovid Therapeutics, Inc., a VP & Head-Multiple Sclerosis Franchise by Novartis, Inc., and a General Manager & Managing Director by Biogen, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from St. Joseph's University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNIC, INC. 0,01 % | 26/05/2026 | 1 251 ( 0,01 % ) | 18 715 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | President | 12/07/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| OVID THERAPEUTICS INC. | Directeur des opérations | 11/07/2024 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 01/11/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The College of New Jersey
The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national